✦ LIBER ✦

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study

✍ Scribed by Anita V. Mitra; Elizabeth K. Bancroft; Yolanda Barbachano; Elizabeth C. Page; C. S. Foster; C. Jameson; G. Mitchell; G. J. Lindeman; A. Stapleton; G. Suthers; D. G. Evans; D. Cruger; I. Blanco; C. Mercer; J. Kirk; L. Maehle; S. Hodgson; L. Walker; L. Izatt; F. Douglas; K. Tucker; H. Dorkins; V. Clowes; A. Male; A. Donaldson; C. Brewer; R. Doherty; B. Bulman; P. J. Osther; M. Salinas; D. Eccles; K. Axcrona; I. Jobson; B. Newcombe; C. Cybulski; W. S. Rubinstein; S. Buys; S. Townshend; E. Friedman; S. Domchek; T. Ramon y Cajal; A. Spigelman; S. H. Teo; N. Nicolai; N. Aaronson; A. Ardern-Jones; C. Bangma; D. Dearnaley; J. Eyfjord; A. Falconer; H. Grönberg; F. Hamdy; O. Johannsson; V. Khoo; Z. Kote-Jarai; H. Lilja; J. Lubinski; J. Melia; C. Moynihan; S. Peock; G. Rennert; F. Schröder; P. Sibley; M. Suri; P. Wilson; Y. J. Bignon; S. Strom; M. Tischkowitz; A. Liljegren; D. Ilencikova; A. Abele; K. Kyriacou; C. van Asperen; L. Kiemeney; The IMPACT Study Collaborators; D. F. Easton; Rosalind A. Eeles

Book ID: 110923165
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 458 KB
Volume: 107
Category: Article
ISSN: 1464-4096
DOI: 10.1111/j.1464-410x.2010.09648.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Absence of 185delAG mutation of the BRCA

Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer

✍ Lehrer, S; Fodor, F; Stock, RG; Stone, NN; Eng, C; Song, HK; McGovern, M 📂 Article 📅 1998 🏛 Nature Publishing Group 🌐 English ⚖ 449 KB

The impact of contralateral mastectomy o

The impact of contralateral mastectomy on mortality in BRCA1 and BRCA2 mutation carriers with breast cancer

✍ Steven A. Narod 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 133 KB

Impact of recent screening on predicting

Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen : Data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden

✍ Andrew J. Vickers; Angel M. Cronin; Gunnar Aus; Carl-Gustav Pihl; Charlotte Beck 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB 👁 2 views

## Abstract ## BACKGROUND: Risk models to predict prostate cancer on biopsy, whether they include only prostate‐specific antigen (PSA) or other markers, are intended for use in all men of screening age. However, the association between PSA and cancer probably depends on a man's recent screening hi

Serum testosterone is associated with ag

Serum testosterone is associated with aggressive prostate cancer in older men: results from the Baltimore Longitudinal Study of Aging

✍ Phillip M. Pierorazio; Luigi Ferrucci; Anna Kettermann; Dan L. Longo; E. Jeffrey 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 261 KB

SERUM TESTOSTERONE IS ASSOCIATED WITH AG

SERUM TESTOSTERONE IS ASSOCIATED WITH AGGRESSIVE PROSTATE CANCER IN OLDER MEN: RESULTS FROM THE BALTIMORE LONGITUDINAL STUDY OF AGING

✍ Abraham Morgentaler; Ernani L. Rhoden; Andre Guay; Abdulmaged Traish 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

Contribution of BRCA1 and BRCA2 germ-lin

Contribution of BRCA1 and BRCA2 germ-line mutations to the incidence of breast cancer in young women: Results from a prospective population-based study in France

✍ Valerie Bonadona; Olga M. Sinilnikova; Sandrine Chopin; Antonis C. Antoniou; Her 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB 👁 2 views

## Abstract The prevalence of __BRCA1/2__ germ‐line mutations was assessed in a prospective population‐based series of early‐onset breast cancer (BC) patients in France, and the usefulness of a clinical assessment of hereditary BC risk, based on multiple criteria including pedigree structure, was e